Pliant Therapeutics Inc (PLRX) Stock Analysis

Pliant Therapeutics Inc (PLRX) is a publicly traded company in the HEALTHCARE sector. It trades at $1.16, carries a market capitalization of $74.30M. This page summarizes the public market data, fundamentals, and frequently asked questions for PLRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Pliant Therapeutics Inc currently has a Neutral sentiment score of 0.03.

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to the discovery and development of innovative therapies for fibrosis and related diseases. The company is advancing a robust pipeline that includes treatments for conditions such as idiopathic pulmonary fibrosis, reflecting its commitment to addressing critical unmet medical needs in this area. Leveraging its deep expertise in fibroblast biology and small molecule drug ...

GNG Research Analysis

GNG Research scores Pliant Therapeutics Inc (PLRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PLRX.

Frequently Asked Questions

Does PLRX pay dividends?

Pliant Therapeutics Inc (PLRX) does not currently pay a regular dividend.

What is PLRX's market cap?

Pliant Therapeutics Inc (PLRX) has a market capitalization of $74.30M with a current stock price of $1.16.